NanoVation Therapeutics is a pioneer in the design and creation of lipid nanoparticles (LNPs) for nucleic acid delivery. The company’s LNP technologies aim to overcome the limitations of existing nucleic acid delivery approaches, including the ability to target tissues outside the liver (extrahepatic delivery). NanoVation’s lead technology is its proprietary long-circulating LNP (lcLNP™) platform, which enables functional nucleic acid delivery to extrahepatic cell types and…
Saved company profile
Historical company information from a saved The Jobs API profile (LinkedIn/Crunchbase fields). It is not live-verified; figures may have changed. Missing values remain unknown.
Delivering tomorrow's genetic medicines, today™
Full company description
NanoVation Therapeutics is a pioneer in the design and creation of lipid nanoparticles (LNPs) for nucleic acid delivery. The company’s LNP technologies aim to overcome the limitations of existing nucleic acid delivery approaches, including the ability to target tissues outside the liver (extrahepatic delivery).
NanoVation’s lead technology is its proprietary long-circulating LNP (lcLNP™) platform, which enables functional nucleic acid delivery to extrahepatic cell types and has demonstrated an improved therapeutic index in preclinical studies.
NanoVation partners with leading pharmaceutical and biotech companies develop genetic medicines for previously untreatable diseases.
NVTx is delivering tomorrow's genetic medicines, today.
For more information, please visit nanovationtx.com.
LinkedIn followers
13,057
People associated on LinkedIn
43
Reported office locations
2665 East Mall, Vancouver, British Columbia V6T 1Z4, CA
Other recorded names
NanoVation Therapeutics
NanoVation Therapeutics™
Specialties
lipid nanoparticles
Profile identifies a recruitment agency
No
Industry
Biotechnology Research
Size
11-50 employees
Headquarters
Vancouver, British Columbia
Organization type
Privately Held
Year founded
2020
Specialties
lipid nanoparticles
NanoVation Therapeutics has 1 open jobs in Canada as of November 7, 2026. Top locations: Vancouver.
NanoVation Therapeutics: The company’s LNP technologies aim to overcome the limitations of existing nucleic acid delivery approaches, including the ability to target tissues…
5+ YOENanoVation Therapeutics needs candidates with a PhD in immunology, pharmaceutical sciences or life sciences and 5+ years of related experience. They must have hands-on lipid nanoparticle expertise, proven team leadership and strong written and oral communication.